Ulf Bladin, Board member since 2019.

Born 1964.

Medical candidate from Karolinska Institutet, B.Sc. and Master from Stockholm School of Economics. Currently CEO of Prolight Diagnostics. Has previously been, among other things, General Manager, Vice President of EMEA Region at Hycor Biomedical, Vice President Commercial Operations Europe at Thermo Fisher Scientific Immuno Diagnostics Division, Vice President with global responsibility for Marketing, Health Economy, Corporate Communications, Scientific & Regulatory Affairs at Phadia AB. Ulf Bladin has also held leading commercial positions in the pharmaceutical industry at Pfizer and Merck Sharp & Dohme.

Other ongoing assignments: CEO and board member of Prolight Diagnostics AB (publ.), board member of  SpectraCure AB (publ), SPCIN AB and UB Management Invest AB.

Shares held privately and via related parties: 120,000

Independent of company, independent of larger shareholders.